Statistics from Altmetric.com
Hall EM, Yin DE, Goyal RK, et al. Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection. J ImmunoTher Cancer 2021;9:e001225. doi: 10.1136/jitc-2020-001225
This article has been corrected since it first published. The provenance and peer review statement has been added.